NCT05975424View on ClinicalTrials.gov

LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1

Active, not recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

June 13, 2018

Primary Completion Date

January 14, 2033

Study Completion Date

January 14, 2033

Conditions
Spinal Cord Injuries
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

Observational study; annual MRI for first 5 years only to monitor changes in the injection site

Trial Locations (6)

19107

Thomas Jefferson University, Philadelphia

30309

Shepherd Center, Atlanta

53226

Medical College of Wisconsin, Milwaukee

60612

RUSH University Medical Center, Chicago

90033

University of Southern California, Los Angeles

94304

Stanford University, Palo Alto

Sponsors
All Listed Sponsors
lead

Lineage Cell Therapeutics, Inc.

INDUSTRY

NCT05975424 - LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1 | Biotech Hunter | Biotech Hunter